Taiyen Biotech Co., Ltd.

NT$29.95As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1737Consumer Staples
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 4.53%
Div yield 4.67%
ROE 5.87%
Household & Personal Products
Beta (5Y) 0.13
PE TTM 15.44
TSR TTM (1.89%)
Mkt cap NT$5.990B
ROIC 6.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$39
28.64%
(63.69%)
Hold 12|2|12|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.55
0.61
0.63
0.68
(0.39%)
13.35%
10.87%
17.31%
RevenueNT$M
298.5
291.8
291.7
303.4
0.31%
0.70%
3.73%
3.95%
Peers (US$180.9M)
Cap (US$)
PE
304.2M
9.750x
188.6M
11.77x
180.5M
51.84x
Capital
TTM
5Y
10Y
Leveragex
1.099
0.208
0.116
EBIT/Intx
0.238
0.566
0.540
Own earn%
(33.17)
(77.49)
(88.93)
Sh yield%
36.92
23.48
24.20
Owners
Insiders/Inst%
8.58
85.81
Short interest%
0.84
SBC / revenue%
1.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
7–13
$1 testx
—
Incr. ROIC%
11